Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. IRT
7. QCOM
8. ASO
9. LAES
10. UNFI

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results

Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q2 EPS

August 8, 2022 5:06 PM EDT

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Corvus Pharmaceuticals, Inc. (CRVS) click here.

... More